Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Teva
Healthtrust
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Express Scripts
Covington

Generated: May 28, 2018

DrugPatentWatch Database Preview

Etonogestrel - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for etonogestrel and what is the scope of etonogestrel freedom to operate?

Etonogestrel
is the generic ingredient in two branded drugs marketed by Organon Usa Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Etonogestrel has seventy-nine patent family members in thirty-one countries.

There are five drug master file entries for etonogestrel. One supplier is listed for this compound.
Summary for etonogestrel
Pharmacology for etonogestrel
Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Synonyms for etonogestrel
(17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one
(17|A)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one
(17alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one
(1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
048E101
13-Ethyl-11-methylene-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one
13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
13-Ethyl-17-hydroxy-11-methylidene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (3-Ketodesogestrel)
165050-21-5
17-Ethinyl-17-beta-hydroxy-18-methyl-11-methylene-4-estren-3-one
17alpha-ethynyl-17beta-hydroxy-11-methylidene-18a-homo-estr-4-en-3-one
18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-
18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-
3-Keto Desogestrel
3-Keto-desogestrel
3-Ketodesogestrel
3-Ketodesogestrel|||3-Oxodesogestrel
3-Oxodesogestrel
3-Oxodesogestrel;3-keto-Desogestrel
304GTH6RNH
54048-10-1
AC1OCEK1
AKOS030526156
AN-40607
BC252319
BDBM50423516
C-23775
CAS-54048-10-1
CC-28331
CHEBI:50777
CHEMBL1531
CS-2884
D02KIU
D04104
DB00294
Desogestrel Related Compound C, United States Pharmacopeia (USP) Reference Standard
DSSTox_CID_26782
DSSTox_GSID_46782
DSSTox_RID_81900
DTXSID9046782
EINECS 258-936-2
Etonogestrel (3-Ketodesogestrel)
Etonogestrel (USAN/INN)
Etonogestrel [USAN:INN:BAN]
Etonogestrel, >=98% (HPLC)
Etonogestrel, United States Pharmacopeia (USP) Reference Standard
etonogestrelum
FT-0652914
GTPL7590
HY-B0652
Implanon
Implanon (TN)
MolPort-003-847-336
NCGC00168777-01
nexplanon
NuvaRing (TN)
ORG 3236
Org-3236
s4673
SCHEMBL117703
Tox21_112638
UNII-304GTH6RNH
ZINC11680067

US Patents and Regulatory Information for etonogestrel

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Organon Usa Inc NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Organon Usa Inc NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Organon Usa Inc IMPLANON etonogestrel IMPLANT;IMPLANTATION 021529-001 Jul 17, 2006 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for etonogestrel

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc IMPLANON etonogestrel IMPLANT;IMPLANTATION 021529-001 Jul 17, 2006 ➤ Sign Up ➤ Sign Up
Organon Usa Inc IMPLANON etonogestrel IMPLANT;IMPLANTATION 021529-001 Jul 17, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for etonogestrel

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
80027 Netherlands ➤ Sign Up PRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825
/1999 Austria ➤ Sign Up PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825
9C0041 Belgium ➤ Sign Up PRODUCT NAME: ETONOGESTREL; NATL. REGISTRATION NO/DATE: 52 IS 296 F 14 19990531; FIRST REGISTRATION: NL RVG 21168 19980825
C/GB99/044 United Kingdom ➤ Sign Up PRODUCT NAME: ETONOGESTREL; REGISTERED: NL RGV21168 19980825; UK 00065/0161 19990609
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Fish and Richardson
Federal Trade Commission
Cipla
McKinsey
UBS
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.